Company: IONQ
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0000950170-25-027722
Chunk: 61

Company: IonQ, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 6
Chunk 61
---
3

         Stock options outstanding

         16,687,129

         21,664,377

         Warrants to acquire common stock

         543,152

         8,301,202

         Public warrants outstanding

         2,320,696

         5,228,253

         Restricted stock units outstanding

         14,509,717

         15,107,535

         Performance-based restricted stock units grants

         11,916,771

         12,923,499

         Shares available for grant under the 2021 Equity Incentive Plan

         22,532,379

         14,075,832

         Shares available for issuance under the Employee Stock Purchase Plan

         5,354,000

         5,354,000

         Total common stock reserved

         73,863,844

         82,654,698

        13. WARRANT TRANSACTION AGREEMENT  In November 2019, contemporaneously with a revenue arrangement, the Company entered into a contract, pursuant to which the Company agreed to issue warrants to acquire shares of Legacy IonQ Series B-1 preferred stock (the “Warrant Shares”) to a customer, subject to certain vesting events. Upon closing of the Business Combination, these warrants exercisable for Legacy IonQ Series B-1 preferred stock were assumed by the Company and converted into a warrant to purchase shares of common stock. Except as specifically provided in the Merger Agreement, the Warrant Shares will have the same terms and be subject to the same conditions (including applicable vesting conditions) as set forth in the Legacy IonQ warrant agreement. The contract allowed for the customer to acquire up to 8,301,202 shares of common stock in the Company. The fair value of the Warrant Shares at the date of issuance was determined to be $8.7 million. As the Warrant Shares were issued in connection with an existing commercial agreement with a customer, the value of the Warrant Shares was determined to be consideration payable to the customer and consequently was treated as a reduction to revenue recognized under the corresponding revenue arrangement. In August 2020, 543,152 of the Warrant Shares vested and became immediately exercisable. The exercise price for the vested Warrant Shares is $1.38 per share and the warrant is exercisable through November 2029. As of December 31, 2024, no additional Warrant Shares can be vested pursuant to